Omicron and new coronavirus variants
This page provides an overview of what is known about the Omicron variant so far and a summary of the UK Government's response.
Research from the Commons Library and POST on Covid-19 vaccines and the UK vaccination programme.
Explore the progress of Covid-19 vaccines research, international initiatives for global access, UK vaccination policy, and what we know so far about the roll out of the Covid-19 vaccination programme.
This page provides an overview of what is known about the Omicron variant so far and a summary of the UK Government's response.
Addressing commonly asked questions about the roll-out of the Covid-19 booster vaccine.
An overview of the regulatory concerns associated with batches of the Vaxzevria (previously called AstraZeneca) vaccine that were manufactured in India and the associated travel issues.
A briefing for the debate on an e-petition relating to Covid-19 vaccine passports.
An overview of the rules surrounding COVID-19 and returning to work, and related issues including childcare and vaccination.
An overview of UK vaccination policy, including an introduction to the science of vaccination and UK vaccination programmes.
Answering commonly asked questions about the roll-out of the Covid-19 vaccine.
The challenge to secure enough vaccines for the world’s poorest and most vulnerable people.
A new generation of COVID-19 vaccines could support vaccination strategies in the long term. But what are the latest developments from preclinical and clinical trials?
What are the key factors to consider when developing long-term immunisation strategies? What are the key unknowns and how can they be addressed?
As the UK COVID-19 immunisation programme reaches all adults, the Government has announced an update to its policy on using a COVID-19 vaccine in children. So, how does COVID-19 affect children? What will the impact of vaccinating children be on preventing disease and minimising associated risks?
The COVID-19 vaccination programme launched in January 2021. All adults over 18 have now been offered the vaccine, although it was reported that 1.3 million people who had been offered a vaccine had not received it.
The B.1.617.2 variant was first observed in India and is rapidly spreading in the UK. What is known about effectiveness of vaccines against this variant - and how close to the finish line are the other vaccines already secured by the UK?
Real-world data shows that COVID-19 vaccines deployed in the UK are effective in protecting against SARS-CoV-2 transmission already after a single dose. Are all the other COVID-19 vaccines equally effective?
The safety of COVID-19 vaccines currently deployed in the UK is closely monitored. This monitoring has shown that the University of Oxford/AstraZeneca vaccine is associated with very rare blood clots. What is known about these very rare adverse events?
The types and sources of COVID-19 vaccine misinformation and its public health impact.
What is the latest evidence on the effectiveness of the COVID-19 vaccines used in the UK on new variants?
The impact of COVID-19 vaccines on transmission of the virus and the potential implications of vaccine-induced protection for easing lockdown restrictions.
The evidence behind the decision to extend the interval between the first and second dose of the Pfizer/BioNTech and University of Oxford/AstraZeneca vaccines
How does the performance of vaccines under real world conditions differ from clinical trial results?
How are vaccines made and what is the UK Government doing to accelerate vaccine manufacture?
Explaining the most common scientific terms used in research that relates to Covid-19.
How is vaccine safety measured and what happens when side effects are found?
With several potential vaccines approaching the end of clinical trials, a new focus is how they will be approved for general use.
Which COVID-19 vaccines are closer to the finish line? Which ones have been approved already for use in humans?
The UK Government secured early access to 340 million doses of six different Covid-19 vaccine candidates.
There are almost 150 coronavirus vaccine candidates under development. Only 19 of these are now being tested in humans.
Who is working on a vaccine to prevent Covid-19 and when might a Covid-19 vaccine become available?
Read the latest coronavirus (Covid-19) research and analysis from the Commons Library and other parliamentary research services.